| Symbol |
Name |
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTN1
|
actinin, alpha 1
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
APLN
|
apelin
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARRB2
|
arrestin, beta 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATOX1
|
antioxidant 1 copper chaperone
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCHE
|
butyrylcholinesterase
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BSCL2
|
Berardinelli-Seip congenital lipodystrophy 2 (seipin)
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CD47
|
CD47 molecule
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CMA1
|
chymase 1, mast cell
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
COL2A1
|
collagen, type II, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL5A1
|
collagen, type V, alpha 1
|
|
COL9A2
|
collagen, type IX, alpha 2
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSL
|
cathepsin L
|
|
CUL5
|
cullin 5
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DCN
|
decorin
|
|
DDR2
|
discoidin domain receptor tyrosine kinase 2
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DES
|
desmin
|
|
DMD
|
dystrophin
|
|
DSG1
|
desmoglein 1
|
|
DYSF
|
dysferlin
|
|
EDN1
|
endothelin 1
|
|
EFNA1
|
ephrin-A1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELN
|
elastin
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FGF16
|
fibroblast growth factor 16
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGG
|
fibrinogen gamma chain
|
|
FHL2
|
four and a half LIM domains 2
|
|
FHL3
|
four and a half LIM domains 3
|
|
FLNA
|
filamin A, alpha
|
|
FN1
|
fibronectin 1
|
|
FNDC1
|
fibronectin type III domain containing 1
|
|
FOXO3
|
forkhead box O3
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IER3
|
immediate early response 3
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL13
|
interleukin 13
|
|
IL1B
|
interleukin 1, beta
|
|
IL32
|
interleukin 32
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
ILK
|
integrin-linked kinase
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB5
|
integrin, beta 5
|
|
ITGB7
|
integrin, beta 7
|
|
IVL
|
involucrin
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KCNK4
|
potassium channel, two pore domain subfamily K, member 4
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KRT14
|
keratin 14, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT18
|
keratin 18, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT6A
|
keratin 6A, type II
|
|
LAMA3
|
laminin, alpha 3
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LMNA
|
lamin A/C
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
|
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIR137
|
microRNA 137
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYLK
|
myosin light chain kinase
|
|
MYO1A
|
myosin IA
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
NRG1
|
neuregulin 1
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
PALLD
|
palladin, cytoskeletal associated protein
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PIEZO2
|
piezo-type mechanosensitive ion channel component 2
|
|
PIGF
|
phosphatidylinositol glycan anchor biosynthesis, class F
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLAT
|
plasminogen activator, tissue
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
PRDX1
|
peroxiredoxin 1
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTN
|
pleiotrophin
|
|
PTX3
|
pentraxin 3, long
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
REST
|
RE1-silencing transcription factor
|
|
RHOA
|
ras homolog family member A
|
|
RNF213
|
ring finger protein 213
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RTN4
|
reticulon 4
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100A12
|
S100 calcium binding protein A12
|
|
SCN11A
|
sodium channel, voltage gated, type XI alpha subunit
|
|
SDC4
|
syndecan 4
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SFTPB
|
surfactant protein B
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SIRT1
|
sirtuin 1
|
|
SMAD3
|
SMAD family member 3
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOST
|
sclerostin
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP7
|
Sp7 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SSPN
|
sarcospan
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STC1
|
stanniocalcin 1
|
|
SYT1
|
synaptotagmin I
|
|
TAC1
|
tachykinin, precursor 1
|
|
TCAP
|
titin-cap
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLN1
|
talin 1
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TTN
|
titin
|
|
UBC
|
ubiquitin C
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCL
|
vinculin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XYLT1
|
xylosyltransferase I
|
|
YAP1
|
Yes-associated protein 1
|
|
YY1AP1
|
YY1 associated protein 1
|
|
ZYX
|
zyxin
|
